Pranav Pandya

Director, Regulatory Affairs and Quality Assurance,

Accord Healthcare

Pranav Pandya has over 20 years of experience working at different capacities within Canadian and Indian Pharmaceutical industry with a proven track record of leading Quality, Regulatory Affairs and Product Development teams for over 8 years. He is a strong believer of continuous improvement concepts and has run projects in global cross functional teams involving team members from different countries with expertise in regulatory affairs, formulation development, process development and analytical development areas.

Currently working with Accord Healthcare as the Director of Regulatory Affairs and Quality Assurance, Pranav manages a team of six people, and is responsible for ensuring the company’s compliance with Health Canada regulations.  He is also responsible for the Quality Management system, and new product submissions to Health Canada.

Pranav has held previous positions at Pharmascience, Jamp Pharma, Apotex and Pantheon, and currently holds a part-time faculty position at John Abbott College in Montreal.

All Sessions by Pranav Pandya

Printer Friendly See Full Agenda

Day 1: Oct 6, 2020

12:00 pm

12:00 pm

Panel Discussion

Streamlining the Path to Market: Regulatory Modernization – Is Canada a Land of Regulatory Obstacles or Opportunities?

The federal government has faced challenges in updating regulations to keep up with the modern changes to drug discovery and with market access.  The result could be viewed as an onerous regulatory burden or as regulatory clarity paving the way for future opportunities.  Take back to your team actionable insights about:

  • The benefits expected from the current federal regulatory modernization project
  • Whether perceived regulatory burdens can be alleviated or reduced
  • How greater clarity in updated regulations can translate into opportunities for market access

Learn how to reduce regulatory burden and leverage regulatory modernization into increased opportunities

Day 2: Oct 7, 2020

Day 3: Oct 8, 2020